Preclinical
Identify potential failures earlier and inform alternate strategies to keep your program on track
Our Global Metabolomics Solution provides a high-resolution in vivo view of your molecule’s impact on preclinical models to help identify potential clinical risks and plan mitigations before you invest in expensive and time-consuming FiH trials.
Build confidence in the safety and efficacy of your program prior to FiH
See a clearer view of off-target effects and potential toxicity earlier in development
Identify pre-clinical biomarkers of pharmacodynamics, safety and efficacy with high-levels of clinical translatability
In vivo biological screening to guide therapeutic strategy
Our Process: Working with Metabolon
Enlighten your research,
accelerate your discovery.
Contact Us
Talk with an expert
Request a quote for our services or more information on sample types and handling procedures, need a letter of support, or simply have questions about how metabolomics can advance your research.
Corporate Headquarters
617 Davis Drive, Suite 100
Morrisville, NC 27560
Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709
+1 (919) 572-1711
+1 (919) 572-1721
International Headquarters
Metabolon GmbH
Zeppelinstraße 3
85399 Hallbergmoos
Germany
+49 89 99017752